BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 119581
Published online Sep 25, 2026. doi: 10.5527/wjn.119581
Table 10 Net clinical benefit of neutrophil gelatinase-associated lipocalin - renal resistive index vs creatinine at selected thresholds
Threshold probability
Neutrophil gelatinase-associated lipocalin-renal resistive index net benefit
Creatinine net benefit
10%0.120.04
25%0.180.06
40%0.200.08


Write to the Help Desk